AUAUniversity American Urological Association

Practical Implementation of Third-Line Therapies for Refractory Overactive Bladder (OAB) Webcast (2024)

CME Available: https://auau.auanet.org/node/41056

At the conclusion of this activity, participants will be able to:
1. Discuss the third-line therapies available to treat OAB refractory to conservative techniques.
2. Effectively provide counseling regarding advanced treatment techniques with "friendly, nonthreatening" language that does not intimidate the patients.
3. Consider helpful techniques to optimize lead placement for sacral neuromodulation and be comfortable with troubleshooting the device.
4. Incorporate caveats that are important in the delivery of injections in the bladder for treatment of OAB.
5. Incorporate peripheral nerve stimulation options, including the traditional and newer techniques that will be discuss in detail, into their practice as they see fit.

ACKNOWLEDGEMENTS
This educational activity is supported by independent educational grants from:
Astellas

AUA2024: 003IC Genetics and Genomics of Urological Cancers - Current Guidelines and Case-based Discussion to Guide Clinical Practice

CME Available: https://auau.auanet.org/node/40976

At the conclusion of this activity, participants will be able to:
1. Describe key components of genetic risk assessment, genetic counseling and informed consent for genetic testing.
2. Identify elements of genetic test reports including variant classification, variant allele frequency, gene penetrance, biomarkers and clinical actionability.
3. Identify criteria for genetic testing for men with prostate cancer. Understand the clinical implications of genetic result in prostate cancer screening and management of both localized and advanced prostate cancer.
4. Recognize genetic causes, tumor features, and cancer risk associated with Lynch syndrome, and apply gained knowledge to improve care of patients with upper tract urothelial carcinoma.

ACKNOWLEDGEMENTS
This educational activity is supported by independent educational grants from: Astellas, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Lantheus Medical Imaging, Merck & Co., Inc., Novartis Pharmaceuticals Corporation, Pfizer, Inc.

Journal Club 101

Guest: Melissa Kaufman, MD, PHD, FACS

Outline:
Segment #1: History of peer review
Segment #2: Models of peer review
Segment #3: General review best practices
Segment #4: General structure for manuscript review
Segment #5: Granular aspects of manuscript review

BPH: Surgical Treatment

Guest: Bilal Chughtai, MD

Outline:
Segment #1: Bladder Health
Segment #2: Diagnostics
Segment #3: Stents
Segment #4: New MISTs

AUA2024: Surgical Laser Enucleation of the Prostate

Guests: Amy Krambeck, MD and Mark Assmus, MD

Outline:
Segment #1: Why Enucleation
Segment #2: What makes this course special?
Segment #3: What is new this year compared to last year?
Segment #4: What do you think makes this course unique?
Segment #5: Who is the ideal participant?

AUA2024: A Specialized Masterclass for Single-port Robot-Assisted Surgery

Guests: Simone Crivellaro, MD and Ahmed Ghazi MD, MHPE

Outline:
Segment #1 Topic: The need for ongoing surgical education given the rise in introduction of new technologies in urology.
Segment #2 Topic: Current status of Hands-on skills courses in Urology
Segment #3 Topic: History of hands on courses offered at AUA
Segment #4 Topic: Educational approach for surgical training
Segment #5 Topic: Single-port masterclass at AUA a step in a new direction